Advances in Bioscience and Biotechnology

Vol.4 No.6A(2013), Paper ID 32959, 6 pages

DOI:10.4236/abb.2013.46A002

 

Attenuation of nicotine-evoked Ca2+ influx by antibody to the nicotinic acetylcholine receptor α3 subunits in human embryonic kidney cells

 

Shota Kobayashi, Shigeru Yokoyama, Takahiro Maruta, Akiko Muroyama, Hiroaki Yoshikawa, Yasuhide Mitsumoto

 

Laboratory of Alternative Medicine and Experimental Therapeutics, Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
Department of Biophysical Genetics, Kanazawa University Graduate School of Medicine, Kanazawa, Japan
Neurological Center, Kanazawa Nishi Hospital, Kanazawa, Japan
Laboratory of Alternative Medicine and Experimental Therapeutics, Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
Laboratory of Alternative Medicine and Experimental Therapeutics, Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan

 

Copyright © 2013 Shota Kobayashi, Shigeru Yokoyama, Takahiro Maruta, Akiko Muroyama, Hiroaki Yoshikawa, Yasuhide Mitsumoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Kobayashi, S. , Yokoyama, S. , Maruta, T. , Muroyama, A. , Yoshikawa, H. and Mitsumoto, Y. (2013) Attenuation of nicotine-evoked Ca2+ influx by antibody to the nicotinic acetylcholine receptor α3 subunits in human embryonic kidney cells. Advances in Bioscience and Biotechnology, 4, 9-14. doi: 10.4236/abb.2013.46A002.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.